Asana BioSciences, LLC

📍 Lawrenceville, United States🗓 Founded 2014👥 8 employees💰 Last funded 2019
Pharmaceutical Manufacturing🌐 asanabio.com
Website LinkedIn
Asana BioSciences, a clinical-stage biopharmaceutical company, was founded in 2014 with the mission to develop novel, clinically differentiated, best-in-class products that address unmet medical needs and provide new treatment options for cancer patients and those suffering from inflammatory conditions. Seven successful INDs were filed in a short span after founding of Asana and multiple clinical proof of concepts studies have been completed in oncology and immunology/inflammation therapeutic categories. Gusacitinib (ASN002), Asana’s lead immunology asset, is entering phase 3 development. Asana’s lead oncology asset (ASN007 or ERAS-007) has completed phase 1 trials in cancer patients. Multiple drugs from Asana’s portfolio have already been out-licensed/partnered with other biotech companies for further development and commercialization.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Asana BioSciences, LLC?
Asana BioSciences, LLC has 1 investors on record on gritt.io, 1 mid-stage.
When did Asana BioSciences, LLC last raise funding?
The most recent investment in Asana BioSciences, LLC recorded on gritt.io was in 2019.
When was Asana BioSciences, LLC founded?
Asana BioSciences, LLC was founded in 2014.
What industry is Asana BioSciences, LLC in?
Asana BioSciences, LLC operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Asana BioSciences, LLC based?
Asana BioSciences, LLC is headquartered in Lawrenceville, United States.